A total of 221 new drugs for diabetes and related diseases are awaiting FDA approval or are in clinical studies, according to a report from the Pharmaceutical Research and Manufacturers of America. The treatments include 130 for type 2 diabetes, 32 for type 1 diabetes, 14 for unspecified diabetes and 64 for related conditions, with some medications in multiple categories.
Report: 221 new diabetes treatments are under development
SmartBrief Job Listings for Health Care
|Clinical Trials Agreements Specialist (209955)||
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
|Catheter Engineer Manager||
ASAHI INTECC, Orange County CA R&D Center
|Santa Ana, CA|
|Neurovascular Intervention Product Sales Rep, North East||
|Multiple Locations, SL_Multiple Locations|
|Senior Manager, Compliance||
|Director, Office of Device Evaluation||
FDA, Center for Devices and Radiological Health
|Silver Spring, MD|